Skip to main content
OpenTrials
Completed

NCT Number: NCT00307996

The Effect of CoQ10 Administration on Hemodialysis Patients

The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Oxidative stress has been recognized as a potential risk factor for such complications as atherosclerosis in hemodialysis patients. This study investigates whether CoQ10 administration is effective for protecting oxidative stress in hemodialysis patients. The subjects were recruited from day-time hemodialysis patients in Iwata City Hospital. 100 mg CoQ10 was administered every HD for 6 months. Several oxidative and antioxidative markers were measured in plasma at pre, 1, 3, 6 months and after washout.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • hemodialysis for at least 6 months

Exclusion criteria

  • none

Treatment and study plan

Coenzyme Q10 (drug)

Drug

Primary outcomes

  1. Oxidative protein concentration at 6 month

  2. Antioxidant capacity at 6 month

Sponsors and collaborators

Lead sponsor

University of Shizuoka

Other

Registry information

Official study title

The Effect of CoQ10 Administration on the Oxidative and Antioxidative Markers in Hemodialysis Patients

Important dates

Study start
2004
Study completion
2004
First posted
Mar 28, 2006
Registry last updated
Mar 28, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.